IN

Indu Nimesh Madhu

Active Director Director DIN 07985897
DIN 07985897 First appointment Nov 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2017
Shareholding value •••• Premium profile

About Indu Nimesh Madhu

Data last updated:

Indu Nimesh Madhu is a Director at Ripcord Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Ripcord Pharmaceuticals Private Limited reported revenue of ₹21.4 Lakh (FY 2023).

DIN 07985897
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2017
Oldest Company Age 8 yrs
Largest company Ripcord Pharmaceuticals Private Limited · ₹21.4 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20172017₹21.4 Lakh (FY 2023)Active

Board colleagues of Indu Nimesh Madhu

Directorship timeline

Open interactive timeline →
Ripcord Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Indu Nimesh Madhu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indu Nimesh Madhu

Indu Nimesh Madhu currently holds 1 directorship: Ripcord Pharmaceuticals Private Limited (Director, since 21 Nov 2017, revenue ₹21.4 Lakh (FY 2023)).

Indu Nimesh Madhu was first appointed on 21 Nov 2017 as Director at Ripcord Pharmaceuticals Private Limited.

The current boards of Indu Nimesh Madhu's companies include Bhavin Nimesh Madhu (Ripcord Pharmaceuticals Private Limited), Komal Nimesh Madhu (Ripcord Pharmaceuticals Private Limited), Mihir Nimesh Madhu (Ripcord Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available